Skip to main content

vicc

Investigators map genomic landscape of very rare cancer

Feb. 28, 2019—A team of Vanderbilt researchers mapped out the genomic landscape of a metastatic malignant proliferating tricholemmal tumor and identified a targeted treatment for this very rare cancer.

Read more


Discovery of new “checkpoint” points to new cancer immunotherapy option

Feb. 21, 2019—An international team involving Vanderbilt researchers has discovered that a new “checkpoint” protein on immune system cells is active in tumors, and that blocking it — in combination with other treatments — is a successful therapeutic approach in mouse models of cancer.

Read more


Research explores link between stem cell transplant, diabetes

Jan. 17, 2019—Brian Engelhardt is studying why as many as 50 percent of stem cell transplant recipients develop diabetes.

Read more


VICC experts to discuss high risk breast cancer at free seminar June 6

May. 26, 2017—Vanderbilt-Ingram Cancer Center (VICC), in collaboration with the Hereditary Cancer Program and the Vanderbilt Breast Center, is hosting a free seminar, “Are You at High Risk for Breast Cancer?”

Read more


VICC Annual Scientific Retreat slated for May 4

Apr. 20, 2017—Leading cancer investigators from several prominent universities and laboratories will headline the 2017 Vanderbilt-Ingram Cancer Center (VICC) Annual Scientific Retreat May 4.

Read more


Annual Meharry–Vanderbilt–TSU Cancer Partnership retreat April 8

Mar. 23, 2017—The Meharry Medical College, Vanderbilt-Ingram Cancer Center (VICC) and Tennessee State University (TSU) Cancer Partnership will host its 16th Annual Cancer Retreat on April 8.

Read more


Know the facts about ovarian cancer

Sep. 16, 2016—Listening to the body and being aware of individual risks are especially important when it comes to ovarian cancer. Vanderbilt–Ingram Cancer Center provides the facts.

Read more


VICC joins other major cancer centers in HPV vaccine campaign

Feb. 4, 2016—In response to low national vaccination rates for the human papillomavirus (HPV), Vanderbilt-Ingram Cancer Center (VICC) has joined 68 of the nation’s other NCI-designated cancer centers in recommending increased HPV vaccination for the prevention of cancer.

Read more


VICC annual retreat slated for April 30

Apr. 9, 2015—Vanderbilt-Ingram Cancer Center’s annual retreat will be held Thursday, April 30, 8 a.m.—3 p.m. at the Vanderbilt Student Life Center.

Read more


VUMC oncology programs recognized 

Aug. 7, 2014—Becker’s Hospital Review has named Vanderbilt University Medical Center among the “100 Hospitals and Health Systems With Great Oncology Programs.”

Read more


Moses to receive Vanderbilt Distinguished Alumni Award

Jan. 20, 2014—Harold “Hal” Moses, the Hortense B. the Ingram Professor of Cancer Research at Vanderbilt University, is the recipient of the 2014 Distinguished Alumni Award — the highest honor for a member of the Vanderbilt alumni community.

Read more


Franklin Women’s Center to offer bone tests, mammograms

Mar. 14, 2013—The Vanderbilt Franklin Women’s Center at Williamson Medical Center is now offering screening mammograms and bone density tests for patients in the community.

Read more


VIEW MORE EVENTS >